N-methyl-d-aspartate (NMDA) receptor antibodies encephalitis mimicking an autistic regression

Developmental Medicine and Child Neurology

Volumn 58, Issue 10, 2016, Pages 1092-1094

  Hacohen, Yael ^a,b   Wright, Sukhvir ^a,c   Gadian, Jonathan ^b   Vincent, Angela ^a   Lim, Ming ^b   Wassmer, Evangeline ^c   Lin, Jean Pierre ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBAZAM; CLONIDINE; IMMUNOGLOBULIN; MELATONIN; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; OLIGOCLONAL BAND; RITUXIMAB; STEROID;

ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ANTIBODY BLOOD LEVEL; ARTICLE; AUTISM; BEHAVIOR CHANGE; CASE REPORT; CHILD; CLINICAL FEATURE; COMMUNICATION SKILL; DRUG MEGADOSE; ELECTROENCEPHALOGRAPHY; FEMALE; FOCAL EPILEPSY; FOLLOW UP; GENERALIZED EPILEPSY; HUMAN; IMMUNOTHERAPY; PLASMA EXCHANGE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; REMISSION; SOCIAL ADAPTATION; TODDLER;

EID: 84985946932     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/dmcn.13169     Document Type: Article

References (14)

1. Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011; 10: 63–74.
2. Hacohen Y, Dlamini N, Hedderly T, et al. N-methyl-d-aspartate receptor antibody-associated movement disorder without encephalopathy. Dev Med Child Neurol 2014; 56: 190–93.
3. Mohammad SS, Fung VS, Grattan-Smith P, et al. Movement disorders in children with anti-NMDAR encephalitis and other autoimmune encephalopathies. Mov Disord 2014; 29: 1539–42.
4. Kleinig TJ, Thompson PD, Matar W, et al. The distinctive movement disorder of ovarian teratoma-associated encephalitis. Mov Disord 2008; 23: 1256–61.
5. Mohammad SS, Jones H, Hong M, et al. Symptomatic treatment of children with anti-NMDAR encephalitis. Dev Med Child Neurol 2016; 58: 376–84.
6. Lemke JR, Lal D, Reinthaler EM, et al. Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet 2013; 45: 1067–72.
7. Carvill GL, Regan BM, Yendle SC, et al. GRIN2A mutations cause epilepsy-aphasia spectrum disorders. Nat Genet 2013; 45: 1073–76.
8. Lesca G, Rudolf G, Bruneau N, et al. GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction. Nat Genet 2013; 45: 1061–66.
9. Paoletti P, Bellone C, Zhou Q. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci 2013; 14: 383–400.
10. Won H, Lee HR, Gee HY, et al. Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 2012; 486: 261–65.
11. Scott O, Richer L, Forbes K, et al. Anti-N-Methyl-d-Aspartate (NMDA) receptor encephalitis: an unusual cause of autistic regression in a toddler. J Child Neurol 2014; 29: 691–94.
12. Creten C, van der Zwaan S, Blankespoor RJ, et al. Late onset autism and anti-NMDA-receptor encephalitis. Lancet 2011; 378: 98.
13. Wright S, Hacohen Y, Jacobson L, et al. N-methyl-d-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children. Arch Dis Child 2015; 100: 521–26.
14. Byrne S, Walsh C, Hacohen Y, et al. Earlier treatment of NMDAR antibody encephalitis in children results in a better outcome. Neurol Neuroimmunol Neuroinflamm 2015; 2: e130.